Back to 
MAVERICK CAPITAL LTD
MAVERICK CAPITAL LTD
CORT
Showing 0 of 5 quarters
Position history for MAVERICK CAPITAL LTD's holdings in Corcept Therapeutics Incorporated.
No. Maverick Capital exited its CORT (Corcept Therapeutics) position in Q2 2023. Its Q1 2023 13F listed 18,657 shares worth $404,111. Maverick Capital first reported CORT in Q2 2020 and held it in 3 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.